About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Washington | 675 Studies

Clinical Trials Prostate CancerWashington

Prostate Cancer Clinical Trials in Washington

Find 675 clinical trials for prostate cancer near Washington. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 675 trials

Active not recruitingAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)This Phase II study aims to evaluate efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg once a day (QD) doses + abiraterone…NCT06991556·La Jolla, California and 64 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedTestosterone and Olaparib in Treating Patients With Castration-Resistant Prostate CancerThis phase II trial studies how well testosterone (enanthate or cypionate) and olaparib work in treating patients with prostate cancer that has progressed despite hormonal therapy.NCT03516812·Seattle, Washington

Active not recruitingStudy of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCThe purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalutamide in…NCT04821622·Birmingham, Alabama and 311 others

CompletedS1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapyRATIONALE: Androgens can cause the growth of prostate cancer cells. Antiandrogen drugs, such as abiraterone acetate, may lessen the amount of androgens made by the body.NCT01309672·Jonesboro, Arkansas and 204 others

CompletedVidaza to Restore Hormone Thx ProstateThe purpose of this research study is to find out what effects (good and bad) Vidaza has on patients with prostate cancer.NCT00384839·Denver, Colorado and 12 others

CompletedS0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyRATIONALE: Drugs used in chemotherapy, such as docetaxel, prednisone, and atrasentan work in different ways to stop the growth of tumor cells, either by killing the cells or by…NCT00134056·Mobile, Alabama and 553 others

RecruitingInternational Registry for Men With Advanced Prostate Cancer (IRONMAN)Our intent is to establish the International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN) as a prospective, international cohort of minimum 5,000…NCT03151629·Birmingham, Alabama and 120 others

CompletedS0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyRATIONALE: Monoclonal antibodies, such as anti-IL-6 chimeric monoclonal antibody, can block tumor growth in different ways.NCT00433446·Anniston, Alabama and 122 others

CompletedHormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells.NCT00288080·Birmingham, Alabama and 253 others

RecruitingNeoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical ProstatectomyMale adults with a confirmed diagnosis of prostate adenocarcinoma who meet criteria for localized high risk prostate cancer according to the NCCN guidelines and who are eligible…NCT06798558·Washington D.C., District of Columbia and 2 others

CompletedRandomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide AcetateThis was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate.NCT05605964·Mobile, Alabama and 107 others

RecruitingA Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerMedicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer.NCT04729114·Tucson, Arizona and 24 others

RecruitingCancer Experience Registry (CER) for Cancer Patients and CaregiversThe Cancer Experience Registry®: An Online Survey Research Study to Understand the Experiences of Those Impacted By a Cancer Diagnosis.NCT02333604·Washington D.C., District of Columbia

CompletedRadium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild SymptomsTo determine if the addition of radium-223 dichloride to standard treatment is able to prolong life and to delay events specific for prostate cancer which has spread to the bone…NCT02043678·Anchorage, Alaska and 162 others

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

CompletedSafety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate CancerThe standard of care for patients with bone-metastatic, castrate-resistant prostate cancer is chemotherapy.NCT01074138·Chicago, Illinois and 4 others

TerminatedEndoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate CancerRadiation therapy is a well-established treatment modality for clinically localized prostate cancer.NCT01618838·Washington, Virginia

CompletedChemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Androgens can stimulate the growth of prostate cancer cells.NCT00016913·Washington D.C., District of Columbia and 22 others

TerminatedA Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)The study will evaluate the safety, pharmacokinetics and pharmacodynamics of increasing doses of a vaccine-based immunotherapy regimen for patients with prostate cancer.NCT02616185·Tucson, Arizona and 18 others

RecruitingAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)The intention of the study is to demonstrate superiority of AZD2265 relative to standard of care treatments by assessment of radiographic progression-free survival (rPFS) and…NCT07611110·Dothan, Alabama and 150 others

PreviousPage 3 of 34Next

Other Conditions in Washington

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma